Ecolab posted fourth-quarter FY22 adjusted earnings per share of $1.27, which surpassed analysts’ expectations of $1.25. Sales grew +9.1% year-on-year to $3.67 billion, vs. consensus of $3.70 billion.
For Q1 FY23, Ecolab expects adjusted earnings per share of $0.82-$0.90, compared to analysts’ forecast of $0.85.
Following their quarterly results, Ecolab shares got price target hikes from some analysts. RBC Capital increased the price target to $185 from $155, while RBC Capital analyst Ashish Sabadra upgraded the rating to Outperform from Sector Perform.
Wells Fargo boosted the price target to $175 from $168, while maintaining an Overweight rating on the stock.
Barclays raised the price target to $165 from $160, while maintaining an Equal-Weight rating on the shares.
The RSI Indicator for ECL moved into overbought territory on March 06, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ECL advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .
ECL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 277 cases where ECL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on March 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECL as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for ECL turned negative on March 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .
ECL moved below its 50-day moving average on March 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ECL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.157) is normal, around the industry mean (4.653). P/E Ratio (38.831) is within average values for comparable stocks, (80.756). Projected Growth (PEG Ratio) (3.009) is also within normal values, averaging (2.249). Dividend Yield (0.009) settles around the average of (0.042) among similar stocks. P/S Ratio (5.013) is also within normal values, averaging (109.523).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of cleaning, sanitizing, pest control, maintenance and repair products and services
Industry ChemicalsSpecialty